Cargando…

Altered Expression Profile of Renal α (1D)-Adrenergic Receptor in Diabetes and Its Modulation by PPAR Agonists

Alpha(1D)-adrenergic receptor (α (1D)-AR) plays important roles in regulating physiological and pathological responses mediated by catecholamines, particularly in the cardiovascular and urinary systems. The present study was designed to investigate the expression profile of α (1D)-AR in the diabetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xueying, Zhang, Yuanyuan, Leander, Michelle, Li, Lingyun, Wang, Guoshen, Emmett, Nerimiah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977090/ https://www.ncbi.nlm.nih.gov/pubmed/24772448 http://dx.doi.org/10.1155/2014/725634

Ejemplares similares

Kidney Injury Molecule-1 Is Upregulated in Renal Lipotoxicity and Mediates Palmitate-Induced Tubular Cell Injury and Inflammatory Response
por: Zhao, Xueying, et al.
Publicado: (2019)

Role of PPARα and Its Agonist in Renal Diseases
por: Cheng, Ching-Feng, et al.
Publicado: (2010)

QSPR analysis of some agonists and antagonists of α-adrenergic receptors
por: Kawczak, Piotr, et al.
Publicado: (2014)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Suppression of the cough reflex by α(2)-adrenergic receptor agonists in the rabbit
por: Cinelli, Elenia, et al.
Publicado: (2013)

Structural basis of agonist specificity of α(1A)-adrenergic receptor
por: Su, Minfei, et al.
Publicado: (2023)

Altered pharmacological effects of adrenergic agonists during hypothermia
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2016)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea
por: Piwnica, David, et al.
Publicado: (2018)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
por: Silswal, Neerupma, et al.
Publicado: (2012)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea”
por: Gil, Daniel
Publicado: (2018)

PPARα Agonist Oral Therapy in Diabetic Retinopathy
por: Tomita, Yohei, et al.
Publicado: (2020)

The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism()()
por: Huang, Jianfeng, et al.
Publicado: (2013)

Differential Modulation of Beta-Adrenergic Receptor Signaling by Trace Amine-Associated Receptor 1 Agonists
por: Kleinau, Gunnar, et al.
Publicado: (2011)

A PPARα agonist improves metabolic parameters in obesity
Publicado: (2012)

Dual PPAR α/γ Agonists: Continuing Cardiac Concerns
por: Balachandran, Karthik
Publicado: (2019)

Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
por: Ballesteros, Jesus Javier, et al.
Publicado: (2020)

Agonist-Directed Desensitization of the β(2)-Adrenergic Receptor
por: Goral, Vasiliy, et al.
Publicado: (2011)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Staying awake – a genetic region that hinders α(2) adrenergic receptor agonist-induced sleep
por: Gelegen, Cigdem, et al.
Publicado: (2014)

Clonidine, an α2 adrenergic receptor agonist, disrupts reconsolidation of a cocaine-paired environmental memory
por: Denny, Rachel R., et al.
Publicado: (2019)

The Effect of PPARα, PPARδ, PPARγ, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice
por: Harrington, W. Wallace, et al.
Publicado: (2007)

PPARγ Agonist and Angiotensin II Receptor Antagonist Ameliorate Renal Tubulointerstitial Fibrosis
por: Han, Jee-Young, et al.
Publicado: (2010)

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor
por: Warne, Tony, et al.
Publicado: (2011)

Therapeutic potential of PPARα agonist in ligature-induced experimental periodontitis
por: Chen, Ying, et al.
Publicado: (2022)

Neuronal ensembles sufficient for recovery sleep and the sedative actions of α(2) adrenergic agonists
por: Zhang, Zhe, et al.
Publicado: (2015)

Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection
por: Nizari, Shereen, et al.
Publicado: (2016)

Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia
por: Samuelsson, O., et al.
Publicado: (2013)

Adrenergic receptor agonists/hydrocortisone: Lack of efficacy: case report
Publicado: (2021)

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
por: Scatena, Roberto, et al.
Publicado: (2008)

β(2)-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations
por: Laureys, Guy, et al.
Publicado: (2014)

Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity
por: Zhang, Youbo, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor (PPAR) γ and PPARα Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders?
por: Zolezzi, Juan M., et al.
Publicado: (2013)

Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPARα Agonist with Moderate PPARγ Agonist Activity in Healthy Human Subjects
por: Jani, Rajendra H., et al.
Publicado: (2013)

Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice
por: Murru, Elisabetta, et al.
Publicado: (2022)

Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
por: Gurley, Catherine, et al.
Publicado: (2008)

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
por: Heudobler, Daniel, et al.
Publicado: (2018)

Sustained Hypoxic Pulmonary Vasoconstriction in the Isolated Perfused Rat Lung: Effect of α(1)-adrenergic Receptor Agonist
por: Ketabchi, Farzaneh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1stn5englmcba27nenefidg0m1